seed
Stage
About
Allegria Therapeutics is a Basel-based biotechnology company developing therapies that target mast cell dysfunction. The company focuses on acute and chronic mast-cell–driven diseases, including allergic and inflammatory conditions.
Explore Allegria Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.